Fourteen patients were studied by positron emission tomography (PET) within 48 h of onset of a hemispheric ischemic stroke and again 7 days later. After the first set of PET scans, the patients were randomized to receive either nimodipine (n = 7) or a carrier solution (n = 7) by intravenous infusion. The infusions were main tained until the end of the second PET studies. CBF, cerebral blood volume (CBV), oxygen extraction ratio (OER), CMR02, and CMRglc were measured each time. These metabolic and perfusion measurements were per formed by standard methods. A surface map of each met abolic and perfusion measurement in the cortical mantle was generated by interpolating between the available slices. The various surface maps representing the physi ological characteristics determined in the same or subse quent studies were aligned so that all data sets could be analyzed identically using an array of square regions of interest (ROIs). The functional status of each ROI was recorded at the two intervals following the cerebrovascu-Recent animal experiments in focal cerebral isch emia have shown that nimodipine, a calcium chan nel blocker, can reduce histologic brain damage and improve neurologic outcome (Mohamed et al., 1985; Sauter and Rudin, 1986; Germano et al., 1987; Bartkowski et al., 1988), Nimodipine has also been shown to improve clinical outcome in stroke. Gel mers et al. (1988) recently published the results of a human clinical trial of nimodipine in acute ischemic
Summary: Fourteen patients were studied by positron emission tomography (PET) within 48 h of onset of a hemispheric ischemic stroke and again 7 days later. After the first set of PET scans, the patients were randomized to receive either nimodipine (n = 7) or a carrier solution (n = 7) by intravenous infusion. The infusions were main tained until the end of the second PET studies. CBF, cerebral blood volume (CBV), oxygen extraction ratio (OER), CMR02, and CMRglc were measured each time. These metabolic and perfusion measurements were per formed by standard methods. A surface map of each met abolic and perfusion measurement in the cortical mantle was generated by interpolating between the available slices. The various surface maps representing the physi ological characteristics determined in the same or subse quent studies were aligned so that all data sets could be analyzed identically using an array of square regions of interest (ROIs). The functional status of each ROI was recorded at the two intervals following the cerebrovascu-neurons and antagonized depolarization-induced Ca2+ uptake into rat cerebellar granule cells (C ar boni et aI., 1985) . Nimodipine has also been shown to correct cerebral acidosis in ischemia (Meyer et aI., 1986; Hakim, 1986) , with studies indicating that this pH correction is not the result of improved per fusion (Hakim, 1986) . Thus, the relative roles of improving perfusion or metabolism when cerebral ischemia is treated with nimodipine are still uncer tain. In addition, no reports on the effect of nimo dipine on cerebral metabolism and perfusion in hu mans using positron emission tomography (PET) have appeared.
We aimed to test the effectiveness of nimodipine in acute ischemia stroke by observing the evolution of cerebral metabolic functions with PET in nimo dipine-treated stroke patients compared with those receiving placebo. The comparison between nimo dipine and placebo was performed in three cortical regions, identified on the basis of CBF on the first PET scan to be compatible with dense ischemia, penumbra, and normally perfused cortex. Align ment of surface maps produced for each of the five parameters measured in both early and late studies an objective determination of the evolution of the measured cerebral functions.
MATERIALS AND METHODS

Patient selection
The stroke patients studied were selected from those seen by the neurology service and diagnosed to have suf fered cerebral infarction. This diagnosis was made clini cally and with a computed tomography (CT) scan to elim inate hemorrhagic or nonischemic lesions prior to PET study. All patients selected had focal neurological deficits that persisted throughout our studies. Excluded from the study were any patients who were possibly pregnant or whose state was complicated by other medical conditions including hypertension with systolic blood pressure of >200 or diastolic blood pressure of> 120 mm Hg, diabetes mellitus with blood glucose of > 16 mM on admission, liver disease, or severe congestive heart failure. If sub arachnoid hemorrhage was suspected in any of the cases, CT scan and lumbar puncture were used to rule it out. Comatose patients or those suffering from other neuro logical conditions including a previous cerebrovascular accident (CV A) were excluded, as were patients treated with heparin and those with hemorrhagic tendency or re cent surgery. Consents for the study were obtained from the patient whenever possible or from the nearest family relative. The study had the approval of the Ethics Com mittees of the Montreal Neurological Hospital and Insti tute and the Royal Victoria Hospital. Initial assessment included general and neurological examinations, electro cardiogram, chest roentgenogram, routine electrolyte, biochemistry, and hematology determinations, and CT scan. Clinical assessment using Mathew scores was re peated at regular intervals following the CV A. CT scan J Cereb Blood Flow Metab. Vol. 9, No.4, 1989 repeated I week after CV A demonstrated appropriate le sions in all cases.
The first set of PET studies was all completed within 48 h of symptom onset. The following measurements were made: CBF, CMR02, oxygen extraction ratio (OER), ce rebral blood volume (CBV), and CMRg!c. The patients were then randomized to receive either an intravenous infusion of nimodipine or a carrier solution, which was then started and maintained until the end of the second set of PET studies 7 days later. Nimodipine was supplied by Miles Laboratories (Etobicoke, Ontario, Canada) and a fresh dilute solution of nimodipine with 0.2 mg/ml of carrier was prepared by our hospital pharmacy as needed. The starting dose of nimodipine was 1 mg/h and the infu sion rate was adjusted to the maximum tolerable dose not exceeding 2 mg/h. The infusion was decreased if systolic or diastolic blood pressures decreased by > 15%. The in fusate was administered by constant infusion pump (IV 6000 infusion pump; Valleylab, Boulder, CO, U.S.A.). The polyvinyl chloride infusion tubing (NTG set; Valley lab) and solution bottle were covered with aluminum or dark plastic to protect the nimodipine solution from light. Identical tubing and protective measures were used for carrier (placebo) solutions. The seven patients receiving an intravenous "carrier" solution were distributed as fol lows: Two received a solution of 200 g of 96% ethanol, 170 g polyethylene glycol 400, 2 g sodium citrate, and 0.5 g citric acid and five received a solution of 1.88 mg ami noacetic acid and 1.47 mg sodium chloride per milliliter of water, pH adjusted with sodium hydroxide. The rates of infusion of carrier were 5-15 mllh.
Sequence of PET studies
The first set of PET studies was all completed within 48 h of symptom onset. The second series of PET studies was then performed 7 days later. The following mea surements were made: CBF, CMR02, OER, CBV, and CMRg!c.
During each study head position was maintained by an individualized thermoplastic face mask. The studies re quired �6 h to perform and were all performed on the same day in each case.
Determination of physiological functions
Characteristics of our PET camera and the methods we used to determine CBF, CMR02, OER, CBV, and CMRg1c have all been recently published (Hakim et aI., 1987) and will be given here only in brief. The Therascan 3128 system was used in all our PET studies. It is a two ring camera with a transverse resolution of 12 mm and an axial resolution of 12 mm full width at half-maximum. Image planes were separated by 12 mm. In most cases two three-slice scans were collected and interleaved so as to yield slice positions at 30, 42, 48, 54, 60, and 72 mm above the orbitomeatal line, bracketing the central re gions with slices separated by 6 mm.
The raw data obtained were corrected for variations in detector efficiency, dead time , random coincidences using the observed singles rate in each detector, attenuation using a projection thresholds method (Bergstrom et aI., 1983) , and scattered coincidences using a deconvolution method similar to that of Bergstrom et al. (1982) . Raw coincidence data were reconstructed into a 128 x 128 image matrix using the filtered back projection method. Prior to each study a 15-cm-diameter phantom containing 68Ge was scanned to obtain a cross-calibration factor between the scanner measurement and the blood radio activity measurement. This factor, the blood and plasma radioactivity concentrations, and the tomographic images were then combined to yield a map of the functional vari able under study.
The protocol for the measurement of CBF, OER, and CMR02 was similar to that established by Frackowiak et al. (1980) . To determine CBF, the patient breathed air containing [150]C02 at a rate of 4.6 mCilmin. Two lO-min scans yielding six independent slices were taken at equi librium along with repeated arterial samples, collected over 15 s, to average the respiratory cycle. The same procedure was then repeated with 150-labeled Oz delivered at 10.6 mCilmin. The activity images from the Oz and CO2 studies were combined to establish the OER on a regional basis. A third PET study was performed using -70 mCi/ min of [150]CO in trace amounts in air to measure CBV at the same positions as for the Oz and CO2 studies (Martin et aI., 1987) . These data were used to correct the apparent OER (Lammert sma et aI., 1983) . CBF values reported were not corrected to a uniform Peo2 level. Knowing CBF, blood volume-corrected OER, and arterial oxygen content, the cerebral CMR02 could be calculated as CMR02 = CBF x OER x Oz content.
[18F]2-Fluoro-2-deoxy-o-glucose ([18F]FDG) was pre pared by a previously published high-yield technique (Diksic and Jolly, 1983) . For CMRg\c studies, patients were fasted and glucose-containing intravenous infusions stopped for 10 h prior to scanning. Five millicuries of [18F]FDG was injected intravenously. Arterial or arteri alized venous samples collected at predetermined inter vals were followed in 40 min by obtaining tomographic images. CMRglc was determined based on the Phelps ex tension for FDG (Phelps et aI., 1979) of the Sokoloff de oxyglucose model. We used four rate constants estab lished in normals by Huang et al. (1980) for our calcula tions. A rearrangement of the operational equation suggested by Brooks (1982) was incorporated in the cal culation of CMRg\c.
Data analysis
The surface map technique For each patient six slices were typically chosen for analysis based on the quality of the images. The object of relating the information contained in these slices to a sur face map of the cortex was to extract, from a series of tomographic images of one particular cerebral function, a unified description of the function with continuity from one slice to the next (Fig. 1 ). An irregular region of inter est (ROI) was outlined by a single cortical contour for each hemisphere in each slice. Typically, the cortical rim defined as the region with the highest perfusion or CMR02 was identified and outlined as an ROlon the contralateral hemisphere and then reflected onto the af fected hemisphere for each slice. In cases where the af fected side was distorted by edema, a different contour was defined for each side. For each 2-mm 2 pixel along the cortical contour, a 5 x 5 array of neighborhood pixels was arranged to provide a mean functional value at that point. While the contour was identified manually as the locus of highest activity on the contralateral side, the neighbor hood averaging rendered the final functional contour in sensitive to displacements of <4 mm. Likewise, the use of a 3 x 3 or 7 x 7 neighborhood array produced essen tially equivalent contours, reflecting the correlated nature of the pixels in a reconstructed image where the intrinsic PET resolution was 12 mm. The contour from each slice was registered in the an teroposterior direction by dropping a projection through a single anchor point for all slices and unfolding the con tours from these as a straight line, then sampling them at 2-mm steps. The axial position of each slice above the orbitomeatal line was then used with the extended con tours to generate an interpolated map in the axial direc tion through linear interpolation at 2-mm intervals. The entire process yielded an image of the cortical surface of the brain as if it had been peeled off and stretched flat. Surface maps were created for each of the six parameters measured in both early and late studies. Care was taken to obtain axial coincidence between the early and late surface maps by applying an appropriate axial offset to one map if needed. This offset was determined by com parison of all six anteroposterior images from the two studies. It was possible to align two data sets to within half an inters lice separation, i.e., 3 mm.
To compare functions and/or studies objectively, a pro cedure was then developed wherein a rectangular grid of 6-mm 2 ROIs was superimposed on each surface map ( Fig.   2 ). Since the various maps were previously aligned in both axial and transverse directions, the grid was used as a template and the functional value in each square could be compared directly with that of the corresponding square in all other functional maps. Once extracted and stored in a data base, any combination of functional val ues from the first or second PET studies could be com pared. This permitted the selection for further analysis of zones of interest, e.g., ranges of CBF and their associated metabolic functions and changes in these parameters over time.
Choice of ROls
The surface map representing CBF on the first PET study was divided into three regions, each consolidating all 6-mm z ROIs with the following mean CBF values: (a)
infarct region with ROIs perfused on the first scan at < 12 ml/l00 g/min; (b) "penumbra" region with ROIs perfused on the first scan between 12 and 18 ml/l00 g/min; (c) "normal" region with ROIs perfused on the first scan at > 18 mUl00 g/min. Once defined on the first scan, these regions remained Table 1) , showing data obtained on the first scan performed within 48 h of the ce rebrovascular accident (left) and data obtained 7 days later (right). The top segment shows visually the increase in CBF between the two scans, which is confirmed in the 6-mm 2 region of-interest representation in the mid dle segment. The change in the CBF vs. CMR0 2 relationship between the two scans is shown in the lowest seg ment.
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Cerebral Blood Flow on Scan I (mil 1 00 g/min) Cerebral Blood Flow on Scan 1I (mil 1 00 g/mln) geographically fixed, the physiological parameters in them were calculated for the first scan, and changes in these functions between the first and second scans in these regions were then measured. It is clear from Tables 2-4 that not every patient showed regions satisfying the three different CBF zones.
Statistical methods
The division of the surface maps into 6-mm 2 ROIs after aligning the metabolic and perfusion functions obtained from both sets of PET studies permitted us to associate metabolic measurements with a predetermined blood flow level. For ease of data handling, these measurements were grouped into three ranges of CBF in the first study as noted above. If a physiological measurement was de rived from fewer than four 6-mm 2 regions in a given per fusion range, it was not retained for analysis since the region was felt to be too small and thus subject to error. This was the only restriction and < 14% of the data was rejected because of it. The physiological functions of the brain regions per fused at the three aforementioned levels were then aver aged and compared. In the first PET study (see Table 2 ), an analysis of variance was used to compare the functions in the cortical regions that were normally perfused, pen-J Cereb Blood Flow Metab, Vol, 9, No. 4, 1989 umbra and most densely ischemic. A two-sided t test was used for these three comparisons and the p values calcu lated. In all our tests, variances for any one variable were pooled from ischemia, penumbra, and normal regions to increase degrees of freedom. It can be seen from the ta bles that these variances are roughly equal for any one particular measurement. Since CBF is a predetermined variable on scan I, it was not statistically compared in the three regions. To assess the effect of nimodipine, patients who received this drug were separated from those who were infused with a carrier solution. In each group, the results on scan II were compared with those on scan I by an analysis of variance method. Tables 3 and 4 show for densely ischemic and penumbra regions, respectively, the change in the measured parameter between the two scans relative to the first determination and the significance of these changes in the groups receiving carrier solution and nimodipine. A two-tailed t test was used here as well. In addition, the significance of the change in the nimodipine group relative to the carrier group is reported.
The reader may wish to make a Bonferroni correction by multiplying the reported p values by 3 to correct for the number of comparisons made in any particular mea sured variable (ischemic region, penumbra, and normal brain). Additionally, the p values could further be multi-plied by 4 to correct for the number of variables mea sured. Table 1 describes briefly the stroke patients stud ied. The age range was 51-73 years (mean ± SEM, 60.7 ± 3. 1 years) in the group receiving carrier and 43-86 years (65.4±5.8 years) in the group receiving nimodipine. The mean ± SEM Mathew scores were 39 ± 7 on admission and 52 ± 5 on day 7 in the group receiving carrier and 55 ± 8 on admission and 63 ± 7 on day 7 in the nimodipine-treated group.
RESULTS
The mean improvement in Mathew scores was not statistically different between the two groups. Clin ically all patients were considered to have suffered a stroke in the anterior cerebral circulation con firmed by CT scan, except for one patient who had a combined posterior cerebral-middle cerebral ar tery territory infarct. Three of the seven patients in the control group were diabetic and three suffered from atrial fibrillation. In the nimodipine-treated group, one was diabetic, one was hypertensive, and two had underlying heart disease. Every effort was made to ascertain as closely as possible the time of onset of the stroke. In the two cases where there was some uncertainty as to the time interval be tween the CVA and the first PET scan, it was ex pressed as a minimum to maximum range. With these maxima, the mean interval between the CV A and PET scanning was 28 h. The time from CV A onset to start of infusion of solution was always <48 h. Four patients who were entered in the study are not shown in Table 1 because they were excluded from further analysis: One of them had unaccept- tients. An early second study had been planned in all patients but was dropped because that schedule was felt to be too strenuous in acutely ill patients.
The last patient excluded from analysis developed significant bradycardia and hypotension in response to even the lowest dose of nimodipine. The other patients tolerated the nimodipine infusion well. A mild asymptomatic decrease in blood pressure (-10--15 mm Hg systolic) was seen in most patients.
Metabolic and perfusion changes
The procedure for the generation of cortical sur face maps for perfusion and physiological functions was followed in each case in both sets of PET stud ies. None of the infarcts showed reactive hyperemia on the first scan. The head position had varied very little within a study and from the first to the second set of studies. Figure 2 presents the information that was ob tained by this method on patient 1, who did not receive nimodipine, on the first and second scans ( Fig. 2 left and right, respectively) . The surface maps for CBF are shown both as a side view and subdivided into 6-mm 2 ROls grouped for the first scan according to the three predetermined CBF ranges. It can be seen that considerable clustering of the ROls occurs within these ranges. For the first scan, the graph shows that CMR0 2 and CBF values obtained from each ROI are linearly related. The equivalent graph obtained 7 days later shows luxury perfusion, since despite little apparent change in the CMR0 2 values of the various zones, CBF had in creased considerably particularly in the infarct and penumbra zones. Table 2 shows that the penumbra region has met abolic and perfusion values intermediate between the densely ischemic core and normal brain. It also shows that the ischemic core on the first scan is distinguished from the normally perfused cortex by its significantly lower CMR0 2 higher OER, and lower CMR g Jc. The region designated as penumbra is also distinguishable from the normal region by its lower CMR0 2 and lower CMR g Jc• These statements would hold even if the p values were scaled for the multiple determinations performed. The relative increase in CBF in the penumbra region (Table 4) is not significantly different be tween the group receiving nimodipine and the group These cortical measurements are divided into ischemic, "penumbra," and "normal" regions defined by the CBF (see text). OER, oxygen extraction ratio ; CBV, cerebral blood volume.
Prototype of data analysis in one patient
Metabolic and perfusion changes
a P value for a two-tailed t test comparing ischemic, penumbra, and normally perfused cortical regions: p value for I-P compares ischemic with penumbra regions, etc.
b No CBF comparisons were made since CBF defined the regions. receiving carrier. There is, however, a significant decline in OER in this region in the group receiving carrier. The group receiving nimodipine showed a rise in CMR0 2 rather than a fall as seen in the car rier group, but these tendencies do not reach statis tical significance. There were no significant changes in any perfusion or metabolic parameter in the nor mally perfused brain in either group.
DISCUSSION
The PET studies presented here were undertaken with a dual purpose: to identify in stroke patients the early characteristics of the densely ischemic and penumbra cortical regions and then to determine how a calcium channel blocker modifies the course of the cerebral functions. The interest in the isch emic penumbra region and its response to therapy arises from our present understanding that follow ing interruption of blood flow to the brain, a pen umbra zone exists between the most densely isch emic core and the more normally perfused brain. In it blood flow is sufficient for cell survival, but not for function (Symon, 1980) . This region is pre-sumed, therefore, to contribute to the clinical defi cit, yet to be capable of responding to therapeutic intervention.
The patients we studied were heterogeneous, showing clinical associations of both embolic and thrombotic strokes: atrial fibrillation in three pa tients, history of hypertension in eight, and diabetes in four. Despite this diversity, PET studies such as those reported here may permit a unified approach to stroke based on metabolic and perfusion mea surements and allow an attempt to further define the penumbra zone. Although the characteristic re versibility of electrical failure in this zone cannot, for obvious reasons, be verified during PET studies, blood flow and physiological characteristics in var ious regions of a brain affected by ischemia can be defined.
A major task faced in our studies was to devise a method that allowed us to reliably compare two sets of PET studies in the same patient. In previous work from this laboratory, when PET studies ob tained at only one time after the CV As were ana lyzed (Hakim et aI. , 1987) , a single slice was se lected to demonstrate the infarct. In studies per- formed two different times, comparing single slices neglected potentially useful information and, if slice alignment was not exact, could lead to erroneous conclusions especially if the stroke area was dif fusely distributed. The data-sampling method used here resulted in superimposable surface maps of metabolism and perfusion obtained during two sets of PET studies and was achieved by resampling from all acceptable transverse images. Both trans verse and axial resolutions, defined as full width at half-maximum of the image line spread and axial response functions, were 12 mm, allowing an im aged volume with relatively isotropic resolution characteristics. Minimal loss of information was in troduced by the resampling procedure used to gen erate the surface maps. Grochowski et ai. (1986) indicate that linear interpolation at the 6-mm inter plane separation used in this study introduces 10% root mean square error for a spectrum containing all frequencies. This error would be expected to be lower for structures having a limited spatial fre quency, such as is found in PET images.
The data indicate that our method of handling PET information in strokes can describe known re lationships: the early coupling between blood flow and oxygen utilization shown on the left of Fig. 2 (Lenzi et aI. , 1982; Baron et aI. , 1983) and its loss when the luxury perfusion evident on the right of Fig. 2 takes place (Lassen, 1966; Lenzi et aI. , 1982) . Although we did not report data on the second scan for the more normally perfused brain regions (CBF > 18 mll100 g/min), CBF and metabolic functions obtained 7 days apart were coincident, implying that the method we used reliably described regions with presumed stable functions over time.
Our most important observation is that changes in cerebral metabolism and perfusion continue to occur in cerebral ischemia for several days after a CVA and may be modified by therapy. The densely ischemic region, on the first scan, has a significantly different CMR0 2 and OER from the normally per fused brain region (Table 2) . Over the subsequent days, this region's CBF more than doubles, but one must conclude that this reperfusion is too slow to be useful since OER significantly declines in the same interval. This combination of findings satisfies the definition of luxury perfusion (Baron et aI. , 1981) . In response to nimodipine, a further increase in CBF is noted, but an important observation is that the change in CMR0 2 in this region is significantly different in the presence of this drug from that in the control group. This may be due either to a more rapid restitution of flow or to a direct cellular met abolic effect of nimodipine. In rats with occlusion of the middle cerebral artery, we have been unable to J Cereb Blood Flow Metab, Vol. 9, No.4, 1989 detect a significant change in CBF in the ischemic region within 4 h of the occlusion (Hakim, 1986; Berger and Hakim, 1988) . It is not known, however, if the CMR0 2 change we observe in this region is metabolically and clinically useful since its postni modipine value is 56.7 ""mol/l00 g/min, which re mains below the level of �67 ""moll100 g/min con sidered by many to be the minimum needed for cell survival (Lenzi et aI. , 1981 (Lenzi et aI. , , 1982 Powers et aI. , 1984) .
The penumbra region we identified had a mean CBF on the first scan of 15.2 ± 0.3 mlll00 g/min, thus satisfying one condition characterizing the ischemic penumbra (Hakim et aI. , 1987) . Table 5 summarizes studies that have identified limits of cerebral tissue's tolerance to ischemia in terms of electrical activity and histological integrity. Based on this literature, we chose for the early penumbra region blood flow limits of 12-18 ml/l00 g/min be cause most investigators identified a CBF of 18 ml/ 100 g/min as the limit below which neuronal activity is interrupted. This interruption is described as be ing reversible until a CBF of 12 ml/l00 glmin is reached, below which the tissue is committed to histologically evident damage. We show that meta bolic characteristics of this region are intermediate between those that are seen in the adequately per fused and densely ischemic brain regions. Com pared with the metabolic events in the control group, the decline in CMR0 2 in this region over time is reversed and that in OER is attenuated by nimodipine. The differences in the changes in CMR0 2 and OER brought about by nimodipine compared with carrier approach but do not reach statistical significance. Reversal in the decline of CMR0 2 , brought about by nimodipine, if confirmed in further studies, may show that this drug could maintain CMR0 2 above the level identified as being incompatible with cell survival.
Several considerations may have limited our abil ity to reach firmer conclusions. The number of pa tients we studied was small, but these were selected from �250 cases evaluated in the emergency room. Our first set of PET measurements, although per formed on average 28 h after the onset of stroke, clearly did not reflect the earliest ischemic cerebral events in our patients. It would be difficult, how ever, to institute measurements such as we per formed much earlier without taking unacceptable shortcuts in the application of the inclusion and ex clusion criteria. Despite this, it is noteworthy that the effect of therapy can still be identified. Rosner and Heiss (1983) have shown that the duration of neuronal viability is dependent not only on the de gree of depression in perfusion but also on its du- ration. Carter et al. (1983) showed that the duration of ischemia after which the direct electrical re sponse of the cortex was unlikely to recover ex ceeded 2 h for a CBF of 17 mlllOO glmin, and others have shown that nimodipine treatment, if begun within 1 rather than 6 h after ischemia onset, re sulted in better neurologic and histologic outcome (Germano et aI. , 1987) . Thus, it is likely that the metabolic and perfusion changes we attribute to ni modipine would have been more striking if treat ment could have been instituted earlier.
Another concern in this type of study is the in fluence of partial volume effects on our measure ments. However, two observations we made are reassuring. The regions identified as penumbra in every case represented the confluence of many pix els (see Fig. 2 ), thus reducing the partial volume effect. To minimize this problem, we have ignored the data when a particular measurement involved fewer than four 6-mm 2 regions. More importantly, the perfusion and metabolic values we identified for the penumbra were intermediate between those for the densely ischemic and normal brain regions on the first but not the second scans. For example, CBF in the penumbra of the nimodipine-treated group was surrounded on the second scan by re gions of higher CBF on either side.
A final consideration is our statistical analysis. We have identified the significance of the changes in the cerebral functions in the control and the ni modipine-receiving groups and compared them. We have also suggested how the p values may be mod ified to account for the multiplicity of measure ments. In the ischemic region, however, significant differences in the changes brought about by nimo dipine compared with carrier solution occurred in more than one cerebral measurement, an event un likely to be due to chance. The same may be thought of the trends seen in the penumbra region. Thus, we can conclude that both CBF and CMR0 2 in the ischemic region are affected significantly dif ferently by nimodipine and carrier solutions and similar tendencies for CMR0 2 and OER are notable in the penumbra region.
Several experimental studies in the literature have shown that calcium channel antagonists exert a protective effect on neuronal tissue under isch emic conditions (Steen et aI., 1983; Mohamed et aI., 1985; Sauter and Rudin, 1986; Bielenberg et aI., 1987a,b; Germano et aI., 1987; Bartkowski et aI., 1988) . Gelmers et al. (1988) Mohamed et aI., 1985; Meyer et aI., 1986) . Our inability to show this in animal stud ies may be related to the onset of drug therapy in relation to the ischemia. Although the clinical ad vantage in reperfusing a brain region that has been densely ischemic for a period of time may be debat able, we have previously shown that patients in whom the ischemic region is reperfused early have better clinical outcomes (Hakim et aI., 1987) . In the penumbra area, reperfusion is an unlikely explana tion for any metabolic improvement since the CBF change was not significantly different in both pa tient groups in this moderately ischemic zone.
Ischemia also induces a loss of Ca 2 + homeostasis and a rise in intracellular Ca 2 + (Harris et aI., 1981).
This may initiate or contribute to several processes that jeopardize neuronal integrity (Farber et aI., 1981; Siesj6, 1981) . Consequences of cellular Ca 2 + overload may include production of free fatty acids such as arachidonic acid and thromboxanes as well as superoxide radicals, ultimately resulting in irre versible loss of mitochondrial function. Ca 2 + accu mulation has been found to be an early event in neuronal cell damage (Deshpande et aI., 1987) and restriction ofCa 2 + entry into cells may thus prolong J Cereb Blood Flow Me/ab, Vol, 9, No, 4, 1989 their viability. Although it has been more difficult to prove restriction of Ca 2 + entry into neuronal cells compared with other cell types, nitrendipine has re cently been shown to inhibit calcium influx into neurons (Thayer et aI., 1986) and to decrease pas sive Ca 2 + entry in purified rat brain synaptosomes (Turner and Goldin, 1985) . Furthermore, Bay K 8644, a calcium agonist, augments 45Ca 2 + cellular uptake, a process that is effectively blocked by ni modipine (Woodward and Leslie, 1985) . The dis covery of dihydropyridine Ca 2 + antagonist receptor sites in human brain and their close relationship to voltage-sensitive calcium channels also supports the concept that Ca 2 + antagonists may act directly on neural tissue by influencing Ca 2 + homeostasis (Bellemann et aI., 1983; Peroutka and Allen, 1983; Gould et aI., 1985; Snyder and Reynolds, 1985; Turner and Goldin, 1985; Van den Kerkoff and Drewes, 1985; Kamp and Miller, 1987) . We have reported that binding to eHlnimodipine is increased in the ischemic regions of the rat brain (Hakim et aI., 1988) .
In conclusion, we show evidence in human cere bral ischemia of cortical zones compatible with dense ischemia and ischemic penumbra that are un stable in their physiologic characteristics. Early af ter the CV A, metabolic function in the penumbra zone may be sufficient for cellular integrity but, without treatment, deteriorates over the ensuing days. Nimodipine enhances the reperfusion of the densely ischemic region significantly, but our data suggest that this is not a significant factor in the penumbra zone. We used a surface map method of data analysis that has general application and could be used equally well to study metabolic responses to therapy in other clinical situations, Thus, our data should provide encouragment for those who continue to seek effective therapy in ischemia. Bielenberg et aI., 1987a,b) . Whether or not the improvement in metabolism we noted with ni modipine treatment is the direct cause of the clinical benefits reported could not be answered by this study.
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